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1172 Abstracts April 2013living patients (84%) were restudied. In 59% of patients there was reduction
of thrombotic burden by >90%, and in 14 (29%) the reduction was 50% to
90%. PA pressures fell from 33 6 8 to 21 6 7 mm Hg, (P < .001).
Decreased PA pressure was not dependent on thrombus reduction.
Comment: The authors’ technique of combined catheter-based
mechanical and pharmacologic treatment of large PE was reasonably
safe, with major bleeding rates of 14% compared with 9% in a recent
meta-analysis of systemic thrombolysis only (Kearon C et al, Chest
2012;141:e419-4S). The data, however, are not completely internally
consistent, in that physiologic improvement in PA pressure did not directly
correlate with the reduction of thrombotic burden. Although it is known
that imaging and physiology do not necessarily correlate precisely in other
vascular beds, the authors’ observations suggest there may be more than
just thrombotic burden contributing to the elevated PA pressures in patients
with PE.Complete Replacement of Open Repair for Ruptured Abdominal
Aortic Aneurysms by Endovascular Aneurysm Repair. A Two-Center
14-Year Experience
Mayer D, Aeschbacher S, Pfammatter T, et al. Ann Surg 2012;256:688-96.
Conclusion: An endovascular aneurysm repair (EVAR)-only
approach to treatment of patients with ruptured abdominal aortic aneurysm
(rAAA) allows EVAR treatment of virtually all rAAA with low mortality and
turndown rates.
Summary: There is controversy regarding the beneﬁt of EVAR in
treatment of patients with rAAA. It has been suggested that improved
mortality rates of rAAA in patients treated with EVAR does not necessarily
reﬂect superiority of the endovascular procedure over the open procedure.
It has been argued that patients with rAAA suitable for EVAR, who are
treated with an open operation, have lower mortality than patients not suit-
able for EVAR treated with open surgery. In addition, it is argued that
patients treated with open surgery are hemodynamically less stable than
those treated with EVAR. The argument, therefore, is that patients treated
with EVAR for rAAA do better as a consequence of being more stable and
anatomically better-risk patients. The authors’ favorable experience with
EVAR for rAAA in the past led them to institute a policy of try-to-treat
rAAA with EVAR whenever possible. In essence, this meant introducing
adjunctive techniques, such as chimney procedures and iliac debranching
as well as coiling of the aneurysm sac, to treatment of rAAA patients with
EVAR. Since May 2009, all rAAA, except one, in the authors’ institutions
have been treated by EVAR. The 30-day mortality was 24%. During the
authors’ EVAR-only protocol for rAAA, only three patients (4%) were
turned down for surgical treatment. From January 1998 until April 2009,
the authors previously used an EVAR/open policy using an “EVAR-when-
ever-possible” approach. In patients in whom abdominal decompression
with laparotomy was performed, no decrease in mortality was observed
for EVAR compared with open repair (unadjusted odds ratio, 1.1; 95%
conﬁdence interval [CI], 0.3-3.7; and adjusted odds ratio, 1.1; 95% CI,
0.3-3.7). There was a trend for increased 30-day mortality for the EVAR
group in 2005 to 2009 compared with 1998 to 2004 (unadjusted odds
ratio, 1.9; 95% CI, 0.8-4.5; and adjusted odds ratio, 1.7; 95% CI, 0.6-4.6).
Comment: Some patients with rAAA who arrive at the hospital alive
are still going to die despite the use of EVAR for treatment. The report,
however, does suggest that anatomic selection bias for apparent improved
mortality rates with EVAR may not be the explanation for the apparent
beneﬁt of EVAR in the treatment of rAAA. EVAR avoids the physiologic
challenge of an open operation for a patient in potential extremis. However,
if the EVAR patient requires abdominal decompression, there is no differ-
ence in mortality compared with an open operation. Although the authors’
approach to treatment of rAAA requires considerable experience with endo-
vascular techniques and a large array of devices immediately available, the
growing ability and willingness to transfer patients with rAAAs to regional
centers suggests that this approach is likely to gain increasing utilization.Characteristics of Ischemic Brian Lesions After Stenting or
Endarterectomy for Symptomatic Carotid Artery Stenosis: Results
From the International Carotid Stenting Study-Magnetic Resonance
Imaging Substudy
Gensicke H, Zumbrunn T, Jongen LM, and the ICSS-MRI Substudy
Investigators. Stroke 2013;44:80-6.
Conclusion: In patients with symptomatic carotid artery stenosis,
those undergoing carotid endarterectomy (CEA) have fewer periprocedural
lesions on diffusion-weighted (DWI) magnetic resonance imaging (MRI)
than those undergoing carotid artery stenting (CAS). CAS DWI lesions
were smaller and more likely to occur in cortical areas and subadjacent white
matter.Summary: The International Carotid Stenting Study (ICSS) random-
ized patients with symptomatic carotid artery stenosis to treatment with
CEA or CAS. The ICSS-Magnetic Resonance Imaging Substudy of ICSS
compared risk of periprocedural cerebral ischemia on MRI between the
two groups. Initial ﬁndings were that 50% of patients treated with CAS
and 17% of those with CEA had one or more new ischemic lesions on
DWI imaging at a median of 1 day after treatment (Bonati LH et al, Lancet
Neurol 2010;9:353-62). However, this initial study provided only
outcomes on a binary basis. Results were only reported as the presence or
absence of one or more new DWI lesions after treatment. This was reported
independently of the total number of lesions, volume of lesions, and loca-
tion of lesions. The authors postulated that comparing the total number
of lesions per patient would provide more information and might be better
suited to compare the risk of periprocedural embolism between treatments.
In this current analysis of the ICSS-MRI substudy, the authors compared
numbers of new DWI lesions between patients with symptomatic carotid
artery stenosis treated with CAS vs CEA. They also analyzed the relative
prevalence of lesions in various patient subgroups, and in addition,
compared volumes of ischemic lesions and location of ischemic lesions
between treatments. There were 124 patients in the CAS subgroup and
107 in the CEA subgroup of ICSS-MRI. CAS patients had higher lesion
numbers than CEA patients (1 lesion, 15% vs 8%; 2-5 lesions, 19% vs 5%;
>5 lesions, 16% vs 4%). The overall risk ratio for the expected lesion count
with CAS vs CEA was 8.8 (95% conﬁdence interval, 4.4-17.5; P > .0001).
Lesion counts were signiﬁcantly increased among patients with lower blood
pressure at randomization, those with diabetes mellitus, those with stroke as
the qualifying event, in patients with left-sided stenosis, and if patients were
treated at centers routinely using ﬁlter-type protection devices during CAS.
Individual lesions were larger in the CEA group than in the CAS group
(P < .0001). Total lesion volume did not differ signiﬁcantly between treat-
ment groups. Lesions in the CAS group were more likely to occur in cortical
areas and in subjacent white matter supplied by leptomeningeal arteries than
lesions in the CEA group (odds ratio, 4.2; 95% conﬁdence interval,
1.7-10.2; P ¼ .002).
Comment: Previous nonrandomized studies have also reported more
frequent occurrence of periprocedural DWI lesions after CAS compared
with CEA. The current study has similar ﬁndings. The volume of ischemic
brain tissue was similar between the two groups secondary to larger lesions
in the CEA vs CAS patients. Of interest is that the authors found higher
rates of DWI lesions associated with the use of ﬁlter cerebral protection
devices. This suggests use of ﬁlter devices for cerebral protection during
CAS may not be the route to improve periprocedural results with CAS.
Because of higher statistical power, analysis of lesion count may be the
preferred method to compare treatment of atherosclerotic carotid artery
stenosis in DWI-based studies.Volume-Outcome Relationships in Lower Extremity Arterial Bypass
Surgery
Moxey PW, Hofman D, Hinchliffe RJ, et al. Ann Surg 2012;256:1102-7.
Conclusion: There is positive volume-outcome relationship for lower
extremity arterial bypass (LEAB) surgery.
Summary: Previous studies have suggested the relationship between
increased case volume and improved outcomes for abdominal aortic aneu-
rysms (AAA) and carotid endarterectomy (Nazarian SM et al, J Vasc Surg
2008;43:343-50; Young EL et al, J Vasc Surg 2007;46:1287-94). Relation-
ships between volumes of LEAB and favorable outcomes were explored in
a recent meta-analysis suggesting beneﬁcial effects with higher surgical
volumes (Awopetu AI et al, Br J Surg 2010;97:797-803). This analysis,
however, pointed out the paucity of studies in the literature on this subject
and the heterogeneity of the studies included in the meta-analysis. In this
study, the authors sought to quantify volume-outcome relationships for
LEAB surgery over a 5-year period. Outcome measures included revision
of bypass surgery, major amputation, and mortality during the initial admis-
sion and at 1 year postprocedure. Multilevel modeling techniques were
used. The studies analyzed all LEAB procedures performed in England
between 2002 and 2006. For each patient, a Charleston-type risk proﬁle,
including operating hospital annual case volume, was identiﬁed. Quintile
analysis and multilevel multivariate modeling were used to identify potential
volume-outcome relationships and to allow adjustment of results for signif-
icant determinacy of outcome. The authors identiﬁed 27,660 femoral popli-
teal bypasses and 4161 femoral distal bypass procedures. With increasing
volume after popliteal bypass there was a decrease in hospital mortality
from 6.5% to 4.9% (P ¼ .0045) and an odds ratio of 0.98 (95% conﬁdence
interval [CI], 0.929-0.992; P ¼ .014) for every increase of 50 patients per
year. Major amputation decreased from 4.1% to 3.2% (P ¼ .006) in high-
volume hospitals, with a reduction in risk of 0.955 (95% CI, 0.928-
0.983; P ¼ .002) at 1 year. For distal bypass, in-hospital mortality decreased
